Pathological diagnosis (n = 17) | n (%) |
---|---|
Patients underwent TBLB | |
Organizing pneumonia | 9 (52.9) |
Acute exacerbation of interstitial lung disease | 3 (17.6) |
Pulmonary adenocarcinoma | 2 (11.8) |
Lymphoma | 1 (5.9) |
Acute eosinophilic pneumonia | 1 (5.9) |
Pneumocystis jirovecii pneumonia | 1 (5.9) |
Multidisciplinary discussion diagnosis (n = 25) | |
Connective tissue disease associated interstitial lung disease | 9 (36.0) |
Acute exacerbation of interstitial lung disease | 6 (24.0) |
Cryptogenic organizing pneumonia | 2 (8.0) |
Pulmonary adenocarcinoma | 2 (8.0) |
Lymphoma | 1 (4.0) |
Acute eosinophilic pneumonia | 1 (4.0) |
Acute lung injury | 1 (4.0) |
Drug induced lung injury | 1 (4.0) |
Pneumocystis jirovecii pneumonia | 1 (4.0) |
Adenovirus pneumonia | 1 (4.0) |
Patients underwent TBLC | n (%) |
---|---|
Pathological diagnosis (n = 18) | |
Organizing pneumonia | 7 (38.9) |
Diffuse alveolar damage | 6 (33.3) |
Aspiration pneumonia | 1 (5.6) |
Lymphoma | 1 (5.6) |
Acute fibrinous organizing pneumonia | 1 (5.6) |
Acute exacerbation of interstitial lung disease | 1 (5.6) |
Cytomegalovirus pneumonia | 1 (5.6) |
Multidisciplinary discussion diagnosis (n = 21) | |
Secondary organizing pneumonia | 3 (14.3) |
Acute exacerbation of interstitial lung disease | 3 (14.3) |
Connective tissue disease associated interstitial lung disease | 2 (9.5) |
Aspiration pneumonia | 2 (9.5) |
Cryptogenic organizing pneumonia | 2 (9.5) |
Graft versus host disease | 2 (9.5) |
Acute lung injury | 1 (4.8) |
Acute fibrinous organizing pneumonia | 1 (4.8) |
Drug induced lung injury | 1 (4.8) |
Lymphoma | 1 (4.8) |
Acute reject reaction after lung transplantation | 1 (4.8) |
Cytomegalovirus pneumonia | 1 (4.8) |
Coronavirus pneumonia | 1 (4.8) |